Status:
TERMINATED
Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy
Lead Sponsor:
Trinity Health Of New England
Conditions:
Hip Injuries
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while...
Detailed Description
Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good p...
Eligibility Criteria
Inclusion
- Patients having hip arthroscopy
Exclusion
- History of neurologic disease, neuropathy, diabetes
- Allergy to local anesthetic solution
- Chronic use of narcotics
- Inability to give consent/cooperate with study
- History of previous hip arthroscopy on the ipsilateral side
- Pregnancy
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2019
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01907191
Start Date
July 1 2013
End Date
January 30 2019
Last Update
August 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States, 06105